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Reconst i tut ion o f  T Cell Receptor  Signaling in 
ZAP-70-def ic ient  Cells by Retroviral Transduction o f  the 
ZAP-  70 Gene 
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Theresa A. Kadlecekfl Lisa Uribe,* Donald B. Kohn,* 
Erwin W. Gelfand,II Arthur Weiss,~ and Kenneth Weinberg* 
From the *Division of Research Immunology and Bone Marrow Transplantation, Children's Hospital 
Los Angeles, Los Angeles, California 90027; :~DNAX Research Institute, Palo Alto, California 94304; 
gHoward Hughes Medical Institute, Department ofMedicine and of Microbiology and Immunology, 
University of California, San Francisco, California 94143; and IIDivision of Basic Sciences and 
Molecular Signal Transduction Program, Department ofPediatrics, National Jewish Center for 
Immunology and Respiratory Diseases, Denver, Colorado 80206 
Summal-y 
A variant of severe combined lmmunodeficiency s ndrome (SCID) with a selective inability to 
produce CD8 single positive T cells and a signal transduction defect in peripheral CD4 + cells 
has recently been shown to be the result of mutations in the ZAP-70 gene. T cell receptor 
(TCR) signaling requires the association of the ZAP-70 protein tyrosine kinase with the TCR 
complex. Human T cell leukemia virus type I-transformed CD4 + T cell lines w.ere established 
from ZAP-70-deficient patients and normal controls. ZAP-70 was expressed and appropriately 
phosphorylated in normal T cell lines after TCR engagement, but was not detected in T cell 
lines from ZAP-70-deficient patients. To determine whether signaling could be reconstituted, 
wild-type ZAP-70 was introduced into deficient cells with a ZAP-70 retroviral vector. High 
titer producer clones expressing ZAP-70 were generated in the Gibbon ape leukemia virus 
packaging line PG13. After transduction, ZAP-70 was detected at levels equivalent to those 
observed in normal cells, and was appropriately phosphorylated on tyrosine after receptor en- 
gagement. The kinase activity of ZAP-70 in the reconstituted cells was also appropriately upregu- 
lated by receptor aggregation. Moreover, normal and transduced cells, but not ZAP-70-deficient 
cells, were able to mobilize calcium after receptor ligation, indicating that proximal TCR sig- 
naling was reconstituted. These results indicate that this form of SClD may be corrected by 
gene therapy. 
S CID is a heterogeneous group of genetic disorders characterized by an absence of T and B lymphocyte 
function. Recently, one form of autosomal recessive SClD 
has been shown to be caused by defects in the ZAP-70 
protein tyrosine kinase (PTK; 1-3). The phenotype of 
ZAP-70-deficient SClD is distinctive with an absence of 
peripheral CD8 + T cells and normal to high levels of pe- 
ripheral CD4 + T cells that cannot signal through the TCR.  
ZAP-70 has a relative molecular mass of 70-kD, and is ex- 
pressed exclusively in thymocytes, T cells, and NK cells (4). 
It contains two tandemly arranged Src homology 2 (SH2) 
domains and a carboxy-terminal k nase domain (5). 
Engagement of the TCR normally results in activation 
of intracellular signal transduction pathways culminating in 
gene expression and cellular proliferanon (6). Much evi- 
dence indicates that initiation of the signal is mediated 
through phosphorylation of two tyrosines located within a 
17-amino acid motif that is present in all conserved chains 
of the TCR,  termed the immunoreceptor tyrosine activa- 
tion motif (ITAM, 7-9). The Src family PTKs Lck and Fyn 
have been shown to play important roles in the tyrosine 
phosphorylation of these ITAMs (10-12). ZAP-70 can 
then associate with the phosphorylated ITAMs of the 
CD3-~ and CD3-~ chains of the TCR through its SH2 
domains (5, 13, 14). ZAP-70 is itself phosphorylated upon 
this interaction, in a process that is dependent on Src family 
PTKs (5, 14-16). The subsequent s eps in the TCR signal- 
ing pathway that result in T cell proliferation and cytokine 
release are not well defined. However, the observation that 
there is an almost complete abrogation of TCR signal 
transduction in CD4 + cells in ZAP-70-deficient patients 
(1-3) indicates a critical role for ZAP-70 in this process. 
Interestingly, there is a second member of this PTK fam- 
ily, termed Syk, that is structurally homologous to ZAP-70 
and shares 57% sequence identity (5, 17). Syk is expressed 
in a wide variety of cells including B cells, mast cells, gran- 
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ulocytes, platelets, and thymocytes, but its level in periph- 
eral T cells is significantly lower (<10% of  the level in B 
cells; 4). Additionally, although Syk is known to be impor- 
tant for signaling in B cells, mast cells, and granulocytes, its 
role in T cell signaling is not clear (18-25). We have re- 
cently shown that high levels of endogenous Syk may par- 
tially compensate for the absence of  ZAP-70 in thymocytes 
from a ZAP-70-def ic ient patient, resulting in signaling 
through the TC1L (26). In contrast with thymocyte signal- 
ing, however, there is a lack of  signaling, as assessed by pro- 
tein tyrosine phosphorylation and mobilization of  [Ca2+],, 
in the peripheral CD4 + T cells from this patient (26). This 
observation again underscores the importance of ZAP-70 
in the signal transduction pathway in peripheral T cells. 
In the present work, we demonstrate successful reconstitu- 
tion of  TCR-mediated signaling in a CD4 + peripheral T cell 
line from this ZAP-70-def ic ient patient. The cell lines have 
previously been shown to have defective TCP,.-mediated sig- 
naling analogous to that seen in primary cells from the patient 
(26). Cells were reconstituted by retroviral-mediated trans- 
duction with the wild-type ZAPo70 gene. After transdnc- 
tion of the patient's cell line, TCR signaling was normalized 
as measured by ZAP-70 phosphorylation, ZAP-70 in vitro 
kinase activity, and reconstitution of calcium mobilization. 
Materials and Methods 
Cell Lines. The patient with ZAP-70 deficiency has been re- 
ported previously (26). Briefly, HTLV-I transformation fpenpheral 
blood T cells from normal adult donors and the ZAP-70-deficient 
patient (AB) were performed as described (27). The normal and AB 
HTLV-I hnes were maintained in RPMI 1640 with 10% FCS, IL-2 
(20 U/ml; gift from Carolyn Paradise, Chiron Corp., Emeryville, 
CA), 2 mM 1-glutamine, 50 U/ml penicillin, and 50 Ixg/ml strep- 
tomycin. The phenotype of control and ZAP-70-deficlent T cell 
lines was similar; each expressed TCR.-oL/I3 as well as CD4. Addi- 
tionally, all cell hnes were IL-2 dependent. The human T leukemia 
cell hne Jurkat was maintained in RPMI 1640 with 10% FCS. 
Construction of the G1ZAPSvNa Vector and Packaqing Line. 
The normal ZAP-70 cDNA (5) was excised fi-om Bluescript 
KS(+) as an EcolLl fragment, blunted with Klenow DNA poly- 
merase, and cloned into the SnaBI site of the pG1XSvNa vector 
plasrmd, a Moloney munne leukemia virus-based retroviral vec- 
tor (28; Genetic Therapy, Inc., Gaithersburg, MD). 
To generate a high tlter packaging line, the resultant pGZAPS- 
vNa plasrmd was transfected into the gp+env 86 ecotropic pack- 
aging hne using DOTAP reagent (Boehnnger Mannheim, India- 
napohs IN) (29). Supematants from the ecotroplc line were then 
used to infect PG13 amphotroplc packaging cells (30), and a sin- 
gle clone with a nter of 4 × 105/ml was used for transductions. 
Retroviral Transductions. pG1ZAP70SvNa supernatants were 
added at a 1:1 dilution to AB cells in logarithmic growth phase 
(105 cells/ml) in the presence of IL-2 (20 U/ml) and 3 ~g/ml 
protamine. Fresh viral supernatants were added every 24 h for 3 
successive days. The AB cells were then &luted to "-'5 × 104 
celts/ml, and 1-ml ahquots were seeded into the wells of a 24- 
well plate and selected m 400 p~g/ml of G418 (geneticin; GIBCO- 
BRL, Galthersburg, MD). In three different ransductions, approxi- 
mately four to eight wells from each plate grew after 3-6 weeks of 
G418 selection. Control cells were transduced with the LN vector, 
which contains only the neomycin phosphotransferase gene (28). 
Immunoprecipitations and Kinase Assays. Cells were starved over- 
mght in RPMI 1640 with 1% FCS (in the absence of IL-2). After 
washing twice in HBSS, cells were resuspended at 2 × 107 cells/ 
nil, incubated with 100 ~1 of a biotinylated ann-CD3 antibody 
(Leu4 mAb; Becton Dickinson & Co., Mountain View, CA) for 
15 min on ice, and then cross-linked with streptavidan (30 p,g/ 
ml, Calblochem/Novabiochem Corp., La Jolla, CA) for 2 rain at 
37°C. Cells were lysed in an NP-40 lysxs buffer (31), and postnu- 
clear supernatants were lmmunoprecapltated with a rabbit poly- 
clonal antibody to ZAP-70, 1222 (5), followed by collectmn on 
protein A/G agarose (Santa Cruz Blotechnology Inc., Santa 
Cruz, CA). Immunoprecipitates were separated on 7.5% SDS- 
PAGE gels and transferred electrophoretically to Hybond mem- 
branes (Amersham, Arlington Hmghts, IL). 
Membranes were blotted with a mixture of the 4G10 (Upstate 
Baotechnology Inc., Lake Placid, NY) and pY72 antiphosphoty- 
rosine mAbs (gift from Bart Sefton, Silk Institute, La Jolla, CA) as 
previously described (31). Blots probed with a ZAP-70-specific 
mAb, 2F3.2 (14), were blocked in TBS (150 mM NaC1, 20 mM 
Tris, pH 7.5) containing 5% BSA and 0.1% Tween 20. Immuno- 
complexes were visualized using the enhanced chemilumines- 
cence detection system (Amersham). 
In vitro kinase assays were performed essentially as reported 
(32). Immunoprecipitates were washed an lysis buffer followed by 
150 mM NaC1 and 50 mM Tras HC1, pH 7.5. Precipitates were 
then incubated m 25 bd kinase buffer (20 mM Pipes, pH 7.0, 10 
mM MnCI> and 5 p, Ci [',/32p]ATP [3,000 Ci/mM]) for 10 man 
at 30°C, washed once, eluted by bolhng in 2× SDS sample 
buffer, resolved on SDS-PAGE, and wsualized by autoradiography. 
Aleasurement of Cytoplasmic Calcium Concentration. T cell lines 
were starved overnight in 1LPMI 1640 with 10% FCS (in the ab- 
sence of IL-2), and were loaded with Indo-1 (Molecular Probes, 
Inc., Eugene, OIL) in the same medium at 20°C for 45 min. Cells 
were washed and resuspended at "°10~' cells/nil in HBSS contain- 
ing 1% BSA. Cells were stimulated with bmtinylated anti-Leu4 
mAb followed by streptavidin at 37°C 111 a constantly stirred 
acrylic cuvette. Fluorescence measurements to determine [Ca2+], 
were performed with a spectrofluorimeter (Photon Technologws, 
South Brunswick, NJ) at an excitation wavelength of 350 nm (4-urn 
bandwidth), and with dual simultaneous momtoring of emission 
at 405 and 485 nm (10-nm bandwidth). The rano of emission at 
405/485 nm was measured at a rate of 2 Hz and is presented as a 
function of time (s). 
Results 
Lack of ZAP-70 Expression in a Peripheral CD4 + Cell Line 
Derived from Patient AB. We have previously shown that pa- 
tient AB, the product of  a consanguineous nion, has ZAP-  
70-deficient SCID (26). This syndrome was diagnosed from 
the patient's peripheral blood T cell phenotype (adequate 
CD4 + count with a marked paucity o fCD8 + T cells), the fail- 
ure of  his PBMCs to mediate increases in [Ca2+], and an ab- 
sence of detectable ZAP-70 protein. Additionally, no ZAP- 
70-specific tLNA could be detected in thymocytes from 
panent AB. To study signaling in peripheral CD4 + cells from 
this patient, an HTLV-I - transformed polyclonal T cell line 
was derived. HTLV-I - transformed CD4 + T cell lines from 
normal individuals were used as controls. Like CD4 + HTLV-I 
lines derived from normal individuals, the patient's HTLV- I  
T cell line expressed CD4, the Lck and Fyn Src family PTKs, 
the TC1L-~ chain, and PLC-y l  (data not shown). All HTLV-I 
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Figure 1. Map of the G1ZAPSvNa vector. Shown are posmons f the 
5' long terminal repeat (5' LTP,), ZAP-70 cDNA, SV-40 promoter/en- 
hancer, neomycin phosphotransferase (ne0) gene, and 3' long tertmnal re-
peat (3' LTR). 
lines required the presence of exogenous IL-2 (20 U/ni l )  in 
the culture medium to sustain growth. In contrast with con- 
trol HTLV-I  lines (Normal), however, ZAP-70 expression was 
not detected in the AB HTLV-I  line (AB; see Fig. 2 B). These 
data indicated that the AB HTLV- I  line could be used as a 
tool to assess whether the transduction of wild-type ZAP-70 
would result in the reconstitution ofTCR-mediated signaling. 
ZAP-70 Is Expressed and Tyrosine Phosphorylated after 
Transduction with GIZAPSvNa.  To determine whether 
wild-type ZAP-70 would restore TCP,. function m AB T cells, 
ceils were transduced with a retroviral vector G1ZAPSvNa, 
into which the entire ZAP-70 cDNA was cloned (Fig. 1). 
Pools of  AB cells from three different ransduction experi- 
ments were selected in G418 for 3-6 wk to obtain cells 
containing GIZAPSvNa (AB/ZAP-70 cells). In these trans- 
duced T cell pools, ZAP-70 was expressed at levels ranging 
from 0.2 to 2.0-fold of  the levels observed in control T cell 
lines (data not shown). In Fig. 2 B, ZAP-70 expression in 
an AB/ZAP-70  T cell pool is equivalent o that observed 
in a normal T cell line (Normal). This indicates that retrovi- 
ral transduction of  ZAP-70 into deficient cells can result in 
approximately normal levels of  ZAP-70 expression. The 
level of  ZAP-70 expressed in six individual pools of  AB/  
ZAP-70-transduced cells did not change after up to 8 mo of 
continuous culture in the absence of  G418, as monitored by 
immunoblot  analysis (data not shown). This result demon- 
strates that ZAP-70 can be stably expressed in cultured T cells 
after transduction with the G 1ZAPSvNa retroviral vector. 
Upon TCR stimulation, ZAP-70 normally associates 
with phosphorylated ITAMs that are present in the CD3-e 
or -{  chains, and is itselfphosphorylated (5, 13-16). There- 
fore, we assessed whether ZAP-70 would be tyrosine phos- 
phorylated in AB/ZAP-70-reconst i tuted cells after recep- 
tor engagement. Cell lines were rested overnight in the 
absence of  exogenous IL-2 before stimulation of  the TCR 
with a biotlnylated anti-CD3 mAb (Leu4) /bilowed by 
cross-linking with streptavidin. In a normal as well as the 
reconstituted cell line (AB/ZAP-70),  the 70-kD ZAP-70 
protein was tyrosine phosphorylated upon TCR aggrega- 
tion. It is interesting to note that several molecular mass 
species of  >70 kD were also tyrosine phosphorylated, al- 
beit at lower levels, in ZAP-70 immunoprecipitates from 
oL-CD3-stimulated normal and reconstituted cell lines. Be- 
cause the phosphotyrosine-reactlve bands in the AB/ZAP-  
70-transduced cells were of  slightly lower intensity than 
those observed in the normal T cells, these higher molecu- 
lar weight species were not evident in the AB/ZAP-70  
lane shown In Fig. 2 A. On longer ECL exposures, how- 
ever, the identical pattern of phosphotyrosine-reactive bands 
ZAP-70 IP Figure 2. Retrovlral-mechated 
"- O ~ transductlon of the wild-type 
ZAP-70 gene results m ZAP-70 
~ expression a d its phosphoryla- 
tion upon CD3 aggregaUon. (A) 
N ZAP-70 was lmmunoprecipi- 
tated using a polyclonal rabbit 
ocCD~ ~= + ~= + === + annbody from a normal PBL line 
It '~  (Normal), a ZAP-70-deficmnt 
91h PBL line (AB), and a ZAP-70- 
~ Q  ~ deficient PBL line reconstituted 
Q Q by retrovlral-me&ated transduc- 
tmn with a wild-type ZAP-70 
0t P-Tyr gene (AB/ZAP-70). 107 cells 
were either unsnmutated (-) or 
b stimulated (+) with a bmtmylated 
antl-CD3 mAb followed by 
~ ~ streptawdin Immunopreclpitated 
[ysates were fractlonated on a 
polyacrylamlde g l, analyzed by 
o/Z~P-70 immunoblottmg with the 4GI0 
monoctonal annphosphotyrosme 
annbody, and developed with enhanced chemiluminescence to assess the 
phosphorylanon status of ZAP-70. (B) The blot was stopped and re- 
probed with a ZAP-70-speclfiC *nAbto assess the level of tmmunopre- 
clpitated ZAP-70. 
was also observed in the AB/ZAP-70 ceils (data not shown). 
This result was reproducible in six tested pools of  AB/  
ZAP-70-transduced cells, with levels of  ZAP-70 ranging 
from 0.2- to 2.0-fold of  those observed in control T cell 
lines. No tyrosine-phosphorylated ZAP-70 would be ex- 
pected, or was observed, in the nontransduced AB ceils or 
in AB cells transduced with the LN vector, since the ZAP-  
70 protein is not expressed in these cells (Fig. 2 and data 
not shown). Thus, one of  the proximal events of  TCR sig- 
naling, the tyrosine phosphorylatlon of ZAP-70 itself, was 
reconstituted in AB/ZAP-70  cells. 
In Vitro Kinase Activity of ZAP-70 Is Activated by TCR 
Stimulation in AB/ZAP-70  Cells. To investigate whether 
ZAP-70 is activated as a result of  CD3 clustering in the re- 
constituted ZAP-70-def ic ient HTLV- I  cell line (AB/ZAP-  
70), an in vitro klnase assay was performed. After CD3 
stlnmlation, immunoprecipitation with a ZAP-70--specific 
antibody was performed in the Jurkat T cell leukemia 
clone, normal and AB HTLV- I  T cell lines, as well as in 
two different pools of  AB-transduced ceils (AB/ZAP-70~ 
and AB/ZAP-70b). Immunoprecipitates were incubated in 
the presence of [2/32p]ATP. ZAP-70 was autophosphory- 
lated inJurkat T cells, as wel l  as in the normal and reconsti- 
tuted AB/ZAP-70  cell lines, but not in the AB cell line 
(Fig. 3). This klnase activity increased upon receptor stimu- 
lation (Fig. 3). Within each cell line tested, the level of  
ZAP-70 protein immunoprecipitated before and after CD3 
cross-linking was the same as that assessed by immunoblot-  
ting with an anti -ZAP-70 mAb. The level of ZAP-70 in the 
AB/ZAP-70b pool (equivalent to that in a normal HTLV- I  
T cell line), however, was approximately fivefold higher 
than in the AB/ZAP-70~ pool (data not shown), account- 
ing for the lower ZAP-70 kinase activity observed in AB/  
ZAP-70~, as compared with the normal and AB/ZAP-70 b 
lines (Fig. 3). Interestingly, a protein with a molecular mass 
of "-'140 kD, which coimmunoprecipltated only in the 
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Figure 3. In vitro kinase activity of ZAP-70 as stimulated byTCR ag- 
gregation i ZAP-70-reconstituted c lls. Jurkat T cells, as well as PBL 
lines from a normal individual (Normal), patient AB, and two different 
pools of ZAP-70-transduced lls (AB/ZAP-70, and AB-ZAP-70b), were 
assessed for autophosphorylation. AfterTCR aggregation (+), lysates from 
107 cells were immunopreclpltated with a polyclonal ZAP-70-speclfiC 
antibody, and anin vitro klnase assay was performed The amount f 
ZAP-70 lmmunoprecipltated before and after stnnulatlon was identical, as 
assessed by c~-ZAP-70 lmmunoblottlng (not shown). 
presence of ZAP-70, was also phosphorylated after TC1L 
stimulation. Although the identity of this second protein is 
not known, its phosphorylation also increased upon TCR 
ligation in both normal and reconstituted cell lines (Fig. 3). 
We are presently analyzing whether the 140-kD protein s 
expressed as a consequence of HTLV-I  transformation, and 
furthermore, whether it can be coimmunoprecipitated 
with antibodies directed against different ZAP-70 epitopes. 
Calcium Mobilization after TCR Stimulation Is Dependent 
on ZAP-70 Expression. The increases observed in cytoso- 
lic calcium concentrations [Ca2+]1 after TCR aggregation is 
absent in ZAP-70-deficient T cells (1-3). Calcium flux is 
one of the proximal events induced upon TCR stimulation 
(10-12, 33-35). We therefore assessed whether changes in 
[Ca2+]. would be observed in reconstituted AB/ZAP-70 
cells. For calcium measurements, cells were loaded with the 
calcium-sensitive dye Indo-1 and stimulated with a biotin- 
ylated CD3 mAb followed by streptavidin. Changes in 
[Ca2+]1 were then monitored by fluorimetry. In contrast to 
AB cells, in which little or no [Ca2+]1 flux was noted, nor- 
mal cells and three different pools of AB/ZAP-70-recon-  
stituted cells (including AB/ZAP-70 a and AB/ZAP-70b) 
had a sustained increase In [Ca2+]1 upon receptor cross- 
linking (Fig. 4 and data not shown). Equivalent loading of 
all cell lines with Indo-1 was affirmed in all experiments by 
demonstrating calcium flux after addition of calcium iono- 
phore (ionomycin; data not shown). 
Discuss ion 
We have shown that retroviral-mediated transduction of 
the wild-type ZAP-70 cDNA into a CD4 + HTLV-I-trans- 
formed T cell line from a ZAP-70-deficient patient results 
t. [ AB 
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Figure 4. ZAP-70 is reqmred for calcium mobilization afi:er TCtL stimula- 
tion. Cells fi'om a ZAP-70-deficlent PBL line (AB), a ZAP-70-reconstltuted 
line (AB/ZAP-7@, and a normal PBL lane (Normal) were loaded wath 
the calcium-sensitive dy Indo-1 and analyzed for increases m [Ca2+],. 
Cells were stimulated wath a baotlnylated oe-CD3 antibody (Leu4-B) fol- 
lowed by streptavadan (SA), as indicated. Changes i n  [Ca2+]l were moni- 
tored by fluonmetrg as a measure ofthe ratio of emission at 405/485 nm 
(ordinate axis) using a Photon Technologies spectrofluonmeter for the in- 
dicated time period (s). 
in reconstitution of the proximal TCtL signaling pathway, 
as assessed by the phosphorylation a d activation of ZAP-70 
itself and by the mobilization of cytosolic calcium. This 
phenotypic orrection was observed in six different pools 
o fT  cells transduced with G1ZAPSvNa. Since the level of 
ZAP-70 in each transduced T cell pool did not vary during 
>8 mo of culture in the absence of G418 selection, this 
retroviral-based vector can be used to achieve stable ZAP-70 
expression. Upon similar transduction of G 1ZAPSvNa into 
normal HTLV-I-transformed T cells, overexpression of 
ZAP-70 could not be achieved, suggesting that high levels 
of ZAP-70 were counterselected in cultured T cells (data 
not shown). Further analyses in animal models will be nec- 
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essary to determine whether T cell polyclonality and diver- 
sity of  the T cell repertoire is maintained after transduction 
with the G1ZAPSvNa retroviral vector. 
Multiple cellular PTKs interact with the TCR and con- 
tribute to the signal transduction pathway, including the 
Src family PTKs Lck and Fyn, as well as the ZAP-70 and 
related Syk PTKs (10-12, 35-38). Increased levels of Syk 
were observed in both the HTLV-i -transformed thy- 
mocyte and peripheral T cell fines derived from the ZAP- 
70-deficient patient described in this report (reference 26, 
and Bacon, K., S. Smith, T. Jahn, T. Kadlecek, A. Weiss, 
K. Weinberg, and N. Taylor, unpublished observations). 
Syk appears to compensate for ZAP-70 only under specific 
cellular conditions; TCR-st imulated calcium flux was ob- 
served in the patient's IL-2-dependent thymocyte cell line 
(26), but not in the IL-2-dependent peripheral T cell line 
derived from the same patient (Fig. 4). Nevertheless, upon 
transition of the patient's peripheral T cell line to IL-2 in- 
dependence with concurrent activation of the JAK/STAT 
klnase pathway, as described previously (39-41), Syk was 
sufficient o mediate a calcium response (Bacon, K., and N. 
Taylor, unpublished observations). Work is in progress to ad- 
dress the relative contributions of these two PTKs to TCR 
signaling in ZAP-70-reconstituted thymocytes and T cells. 
Our experiments focused on the role of ZAP-70 in 
TCR signaling, but the phenotypes of ZAP-70-deficient pa- 
tients and mice indicate that ZAP-70 also plays an impor- 
tant role in T cell development (1-3, 42). ZAP-70-deficient 
patients have normal or increased numbers of CD4 ÷ cells 
with a paucity of CD8 + cells, whereas mice with a targeted 
deletion of the ZAP-70 gene express neither CD8 nor CD4 
single positive T cells (42). Introduction of ZAP-70 into 
hematopoietic stem cells isolated from the ZAP-70-defi-  
cient mouse may provide insights into the biological effects of 
exogenous ZAP-70 expression. It will be important o de- 
termine the bases of the differences between ZAP-70--defi- 
cient patients and mice, however, since gene therapy pro- 
tocols for ZAP-70-deficient SCID patients will have to 
target a progenitor o fT  lymphocytes that is able to achieve 
correction of T cell ontogeny. The present experiments 
demonstrating correction of signal transduction through 
the TCR in a ZAP-70-deficient T cell line lay the founda- 
tion for these further preclinical investigations. 
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